Home » GSK to Pay $750 Million Settlement Over Manufacturing Investigation
GSK to Pay $750 Million Settlement Over Manufacturing Investigation
GlaxoSmithKline (GSK) and the Justice Department have finalized a settlement agreement in which the UK drugmaker will pay $750 million to settle an investigation into a now-shuttered Puerto Rico facility where adulterated drugs were made. The settlement is the fourth largest amount paid by a pharmaceutical company to the U.S. government, Tony West, assistant attorney general for Justice’s civil division, said. GSK is paying a $150 million criminal fine and a $600 million civil settlement under the False Claims Act.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May